4//SEC Filing
Bodick Neil 4
Accession 0001209191-19-016492
CIK 0001419600other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:26 PM ET
Size
9.0 KB
Accession
0001209191-19-016492
Insider Transaction Report
Form 4
Bodick Neil
Chief Medical Officer
Transactions
- Award
Common Stock
2019-03-01+36,000→ 100,782 total - Award
Stock option (right to buy)
2019-03-01+18,000→ 18,000 totalExercise: $14.75Exp: 2029-02-28→ Common Stock (18,000 underlying)
Holdings
- 1,000(indirect: By Spouse)
Common Stock
- 388,683(indirect: By LLC)
Common Stock
Footnotes (2)
- [F1]The shares are held by Versant Development Fund III, LLC. The Reporting Person is a manager and minority member of Versant Development Fund III, LLC. The Reporting Person disclaims any beneficial ownership of the shares held by Versant Development Fund III, LLC except to the extent of his pecuniary interest in these shares.
- [F2]Twenty-five percent (25%) of the shares subject to the option shall vest one year after January 1, 2019 (the "Vesting Commencement Date") and thereafter one-forty-eighth (1/48th) of the total shares shall vest each month following the one year anniversary of the Vesting Commencement Date, so that all of the shares shall be vested four (4) years after the Vesting Commencement Date.
Documents
Issuer
Flexion Therapeutics Inc
CIK 0001419600
Entity typeother
Related Parties
1- filerCIK 0001598099
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 4:26 PM ET
- Size
- 9.0 KB